The Challenges With eSource

By Patrick Smith

While the benefits of eSource’s operational effectiveness and efficiency in clinical trials can speak for themselves, adoption is not always easy. Key regulatory agencies like the FDA have taken significant steps to remove barriers to their approval and detail the considerations eSource trials must take.

The ability of an eClinical vendor to assist with these institutional challenges depends more heavily on the quality of support they can provide than the technology they offer. If your team is considering implementing an eSource trial, have these conversations with your vendor and assess the technical and institutional obstacles that could arise when shifting into eSource from traditional paper trials.